ARAF and cancer: Furthermore, by applying SPT, some key questions in PK biology will begin to be answered, such as (1) is PK organisation affected during cancer progression and metastasis; (2) how do protein effectors modulate signalling strength; and (3) how do PKs differentiate alternative down-stream signalling pathways.